About Biogen, Inc.
Biogen Inc. is a global biotechnology company focused on discovering, developing, and delivering therapies for serious neurological and neurodegenerative diseases, including multiple sclerosis, Alzheimer's disease, and rare neurological disorders. Founded by pioneering scientists in the field of genetic engineering, Biogen has grown into one of the world's leading neuroscience-focused biotech firms, with flagship products spanning MS treatments and newer therapies like LEQEMBI for Alzheimer's. The company continues to expand through strategic acquisitions and a growing pipeline in immunology and rare disease. Biogen was founded in 1978 and is headquartered in Cambridge, Massachusetts.